HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angelas, CA -- (SBWIRE) -- 10/16/2012 -- Shares of ChipMOS TECHNOLOG (NCM:IMOS) are trading at $12.79 and is -12.32% from its 50-day Moving Average price of $14.5869 and +0.15% from its 200-day Moving Average price of $12.7704. The average trading volume is 175022 shares and its market capitalization is $349.3M. ChipMOS Technologies (Bermuda) Ltd(NASDAQ:IMOS) shares declined 8.71% to $12.79 in the morning hour after the company announced that it expects consolidated revenue for the fourth quarter of 2012 to be approximately flat to 5% lower, as compared to the third quarter of 2012, reflecting continued growth in its LCD driver and flash memory testing businesses, offset by continued broader softness in the memory market, which is decreasing the Company’s commodity DRAM assembly business. The Company reported revenues of NTD5.139 billion in the third quarter 2012.
Can IMOS Find The Top Further?Find Out Here
Sarepta Therapeut (NGM:SRPT) is very active today and traded between $25.57 - 29.00 with total traded volume of 6733699 shares. At a current price of 27.36, SRPTis +0.25 - +0.92% from the previous close of $27.11. Moreover, At Current Market Price, SRPT is in distance of +41.64% from its 50-day Moving Average price of $19.3171 and +200.33% from its 200-day Moving Average price of $9.1098. Sarepta Therapeutics (SRPT) presented phase IIb data over the weekend indicating that its eteplirsen treatment for Duchenne Muscular Dystrophy is effective. Piper Jaffray believe that the medication has the potential for accelerated approval and keeps its Overweight on Sarepta with a price target of $38. In a report published Monday, Wedbush Securities reiterated its Outperform rating and $70 price target on Sarepta Therapeutics.
Don't Miss The Opportunity : Get A Free Analyst Report
Shares of Renesola Ltd. Com (NYSE:SOL) are trading at $1.25 and is -13.83% from its 50-day Moving Average price of $1.4506 and -17.65% from its 200-day Moving Average price of $1.5178. The average trading volume is 306698 shares and its market capitalization is $107.9M. ReneSola Ltd ("ReneSola") (NYSE:SOL), a leading global manufacturer of solar photovoltaic ("PV") modules and wafers, today announced that it has shipped 10 MW of its high-quality solar modules to saferay GmbH ("saferay"), a leading large-scale PV power plant installer in Germany. Under the terms of the agreement, ReneSola is delivering a total of 10 MW of its 245 W and 250 W multicrystalline solar modules directly to saferay for use in a new PV power plant near Schwarzheide in Brandenburg, Germany.
Should Investor Exit From SOL : FIND OUT HERE
Dyax Corp. (NGM:DYAX) reported EPS of -0.43. For the Current Fiscal year, the company is expected to report EPS of -0.35. For the Next Quarter and Next Year, the company is expected to report EPS of -0.08 and -0.14 respectively. At Current Market Price, DYAXis in distance of +14.58% from its 50-day Moving Average price of $2.4611 and +31.57% from its 200-day Moving Average price of $2.1433. Dyax Corp (NASDAQ:DYAX) augmented 18.49% to $2.82 on a traded volume of 244k shares.Last month, Dyax Corpand Kadmon Corporationentered into a strategic licensing agreement in which Kadmon has been granted an exclusive worldwide license for the development and commercialization of the fully human monoclonal antibody DX-2400. Under the terms of the agreement, Dyax will receive an upfront paymentand is eligible for significant development and commercial milestone payments.
How Should Investors Trade DYAX Now? Find Out Here
Neither HotPennyStockNews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by HotPennyStockNews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation. HotPennyStockNews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through HotPennyStockNews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein..
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)